Article Information
History
- February 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Paola Storti1,ⱡ,
- Valentina Marchica1,ⱡ,
- Rosanna Vescovini1,ⱡ,
- Valentina Franceschi2,
- Luca Russo2,
- Vincenzo Raimondi1,
- Denise Toscani1,
- Jessica Burroughs Garcia1,
- Federica Costa3,
- Benedetta Dalla Palma4,
- Naomi Soressi4,
- Mariateresa Giaimo1,4,
- Nicolas Thomas Iannozzi1,
- Laura Notarfranchi1,
- Gabriella Sammarelli4,
- Gaetano Donofrio2,* and
- Nicola Giuliani1,4,*
- 1Department of Medicine and Surgery, University of Parma, Parma, Italy
- 2Department of Medical-Veterinary Science, University of Parma, Parma, Italy
- 3School of medicine – “Università del Piemonte Orientale”, Novara, Italy
- 4Hematology, “Azienda Ospedaliero-Universitaria di Parma”, Parma, Italy
- ↵*Corresponding authors: Nicola Giuliani MD, PhD, Department of Medicine and Surgery, University of Parma, Email: nicola.giuliani{at}unipr.it, Gaetano Donofrio, PhD, Department of Medical-Veterinary Science, University of Parma, Email: gaetano.donofrio{at}unipr.it;
↵ⱡ P.S., V.M. and R.V equally contributed to this study.
Posted February 26, 2022.
Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myeloma
